What NovaVision does

NovaVision Inc. is a private digital therapeutics company headquartered in Boca Raton, Florida, that develops FDA-cleared and FDA-registered therapies for neurological vision loss resulting from stroke or brain injury. The company operates as the vision rehabilitation division of Vycor Medical and serves patients who have suffered neurological damage causing hemianopia, quadrantanopia, scotoma, or other visual field deficits. Its portfolio includes Vision Restoration Therapy (VRT), described as the only FDA-cleared therapy for restoring neurological vision loss, which uses repeated light stimulation at the border of intact and damaged visual fields; NeuroEyeCoach, an FDA-registered compensatory eye movement training program with self-adaptive difficulty; and VIDIT, a diagnostic system for clinical visual field screening. The underlying platform combines High-Resolution Perimetry for diagnostic mapping, cloud-connected patient portals for progress monitoring, and PC-based software for at-home therapy delivery.

The company's business model is primarily direct-to-consumer one-time license sales, with a Therapy Suite combining VRT and NeuroEyeCoach priced at $900-$950, NeuroEyeCoach standalone at $450, and a VRT extension module at $300. A freemium online vision screening test serves as lead generation, while two B2B channels — the NovaVision Pro Physician Model and the NovaVision Center Model — distribute the products through physician prescriptions and rehabilitation clinics. The company reports serving patients in the US, Canada, UK, Germany, and Australia, supported by a German partner company, and markets directly via its website, social channels, and patient testimonials. Therapies are not generally covered by health insurance or Medicare/Medicaid, though the company notes some patients achieve reimbursement with documentation. The company is small (11-50 employees), has no disclosed external funding rounds, and relies on the corporate resources of parent Vycor Medical.

Name

NovaVision

Legal name

NovaVision, Inc.

Website

https://novavision.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

NovaVision Inc., a Boca Raton-based division of Vycor Medical, develops FDA-cleared digital therapeutics (VRT and NeuroEyeCoach) that restore or compensate for neurological vision loss in stroke and brain injury patients, selling directly to patients, physicians, and rehabilitation clinics.

Ownership category

akta.pro rank

Product category

Digital Therapeutics for Neurological Vision Rehabilitation

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Low Vision Rehabilitation (HLAKAKAJ), Vision Therapy & Orthoptics (HLAKAKAM), Neuro-Ophthalmology (HLAKAKAH)

Keywords

• Vision restoration therapy
• Neurological vision rehabilitation
• Digital therapeutics
• FDA-cleared therapy
• Stroke vision recovery

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. VRT & NeuroEyeCoach Therapy Suite: Combined therapy suite providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach for $950. Includes $50 refundable chinrest deposit (US) or $165 purchase price (outside US). This is the primary revenue stream representing best value for comprehensive vision rehabilitation.
2. NeuroEyeCoach Standalone: Complete 36 sessions of NeuroEyeCoach Program available separately for $450. For patients who have not suffered vision loss but have eye movement problems, or as follow-on after VRT completion.
3. VRT Extension Module: 3 additional months of VRT available for $300 one-time. For patients who show continued improvement and benefit from extended therapy beyond initial 6-month program.
4. Online Vision Screening Test: Free online visual field screening test to help identify potential vision loss after stroke or brain injury. Serves as lead generation tool driving patient acquisition for paid therapy programs.
5. Chinrest Hardware: Chinrest required for VRT therapy - $50 refundable deposit in US, $165 purchase price outside US. NovaVision covers mainland USA shipping costs.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

NovaVision develops and sells FDA-cleared and FDA-registered digital therapeutics that rehabilitate neurological vision loss caused by stroke or brain injury. Its portfolio includes Vision Restoration Therapy (VRT) — the only commercially available FDA-cleared therapy designed to restore lost vision through neuroplasticity-based light stimulation — and NeuroEyeCoach, a self-adaptive computer-based program for compensatory eye movement training. Therapies are delivered via PC software at home, supplemented by VIDIT diagnostic hardware, HRP perimetry, online screening, and professional physician/clinic portals.

Product overview

NovaVision offers a portfolio of FDA cleared and registered therapies and diagnostic products for vision disorders resulting from stroke or brain injury. The core offerings include Vision Restoration Therapy (VRT) - the only commercially available FDA-cleared therapy for restoring neurological vision loss - and NeuroEyeCoach, a systematic eye movement training program. These are provided individually, as a combined Therapy Suite ($900), and through professional models for physicians and clinics. Supporting products include VIDIT diagnostic system and an Online Visual Field Screening Test.

Differentiator

Problem solved

Functional benefit

Products and services

• Vision Restoration Therapy (VRT) The only FDA-cleared therapy designed to restore vision loss due to neurological brain damage from stroke or brain injury. Uses repeated light stimulus exercises at the border between intact and damaged visual fields to strengthen the brain's visual processing ability. Performed twice daily, six days a week for six months at home on the patient's computer under physician prescription.
• NeuroEyeCoach FDA-registered home-based, computer-based compensatory eye movement training program for stroke and brain injury patients. Trains users to scan their environment more efficiently through visual search tasks with 12 self-adaptive difficulty levels and 36 total sessions. Designed to help patients make the most of remaining vision.
• VIDIT Diagnostic System Diagnostic system enabling therapists and clinicians to perform high-resolution 7-minute visual field tests to screen for central visual field deficits by campimetric testing of the central 20 degrees visual field. Designed for use in rehabilitation centers and clinics.
• NovaVision Online Visual Field Screening Test Free online vision test designed to help determine whether someone has experienced neurological vision loss after stroke or brain injury. Provides instant preliminary results and can be performed at home; serves as a funnel into NovaVision's paid therapy programs.
• NovaVision Therapy Suite (VRT + NeuroEyeCoach bundle) Combined therapy package offering both VRT and NeuroEyeCoach together for $950, providing 6 months of VRT plus complete 36 sessions of NeuroEyeCoach to maximize patient benefit through complementary restoration and compensation approaches.
• VRT Extension Module 3 additional months of Vision Restoration Therapy available as a one-time purchase for patients who show continued improvement beyond the initial 6-month program. Contact Patient Services at 888.205.0800 to extend.
• NovaVision Center Model A program designed for clinics and rehabilitation centers to provide vision diagnosis and rehabilitation using the VIDIT diagnostic system and NeuroEyeCoach therapy, offered at affordable and flexible pricing for in-clinic use.
• NovaVision Pro Physician Model A physician practice offering enabling doctors to register patients for NovaVision therapies and monitor their progress through a dedicated portal, with software, manuals, marketing materials, and technical support provided.
• NovaVision Chinrest Required hardware chinrest accessory used to standardize patient head position during VRT therapy sessions at home. $50 refundable deposit within the US; $165 purchase price outside the US. NovaVision covers mainland USA shipping.

Quantifiable outcome

• 70%+ of VRT patients show measurable visual field improvements
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Vycor Medical (Parent Company)coreOthersNovaVision is the vision rehabilitation division of Vycor Medical. NovaVision operates as a subsidiary or division leveraging Vycor Medical's corporate infrastructure and resources for the neurological vision therapy business.
• German Partner CompanyminorOthersNovaVision has a partner company in Germany supporting European operations and potentially European regulatory/commercial activities.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Posit Science: Posit Science develops BrainHQ, an evidence-based digital therapeutic for cognitive and brain training. Like NovaVision, it operates clinically validated neuro-rehabilitation software sold direct and through clinical channels in the post-stroke / brain injury population.
• RightEye: RightEye uses eye-tracking-based vision assessments to detect neurological issues such as concussion and stroke-related deficits. It targets a similar neurology / brain-injury population with vision diagnostics, directly overlapping NovaVision's VIDIT and NeuroEyeCoach.
• LumiThera: LumiThera develops the FDA-cleared Valeda Light Delivery System, a photobiomodulation device to treat ocular diseases including dry AMD. Comparable to NovaVision in applying light-based neuro-ophthalmic therapies with FDA-cleared/registered devices.
• MindMaze (SyncThink): MindMaze, including the SyncThink platform, uses eye-tracking to assess and treat brain injury and neurological conditions. It overlaps NovaVision in serving post-stroke and TBI populations with technology-driven visual assessments and digital therapies.
• Vispero (Optelec): Vispero, parent of Optelec, Enhanced Vision, and Freedom Scientific, is a leading manufacturer of low-vision aids and assistive technology. Comparable to NovaVision as a vendor of vision rehabilitation solutions to patients with visual impairment.
• HumanWare: HumanWare manufactures assistive technologies for people with visual impairments, including electronic magnifiers, braille devices, and low-vision solutions. Comparable to NovaVision in addressing functional vision needs of vision-impaired patients through specialized products.

Emerging players

• Constant Therapy Health: Constant Therapy delivers digital speech, language, and cognitive therapy to stroke survivors. Adjacent to NovaVision in providing clinically validated digital neuro-rehabilitation sold to patients and clinics post-stroke.

Broad incumbents

• Bioness (Bioventus): Bioness, a Bioventus company, develops electrical stimulation devices for neurological and orthopedic rehabilitation. Comparable as a broader neuro-rehab device incumbent serving stroke recovery with neuromodulation products.
• Tobii: Tobii is a global leader in eye-tracking technology with applications in medical diagnostics, including neurological assessment. Comparable as a broad technology incumbent enabling vision and neurology assessments overlapping NovaVision's diagnostic platform.
• Carl Zeiss Meditec: Carl Zeiss Meditec manufactures ophthalmic diagnostic and surgical devices (OCT, perimeters, fundus cameras) used in vision assessments. Comparable as a broad medical device incumbent in the ophthalmic diagnostic space where NovaVision's VIDIT diagnostic operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/novavision3
• Facebookfacebook.com/novavisionvrt
• LinkedInlinkedin.com/company/novavisioninc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NovaVision